Join to View Full Profile
4588 Carothers PkwyFranklin, TN 37067
Phone+1 615-591-4764
Fax+1 615-591-7947
Dr. Beckermann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kathryn Beckermann is the Director of Genitourinary clinical research at Tennessee Oncology. She specializes in the treatment of patients with kidney, bladder, prostate, and testicular cancer. She completed residency and fellowship in Medical Oncology at Vanderbilt University Medical Center.
Clinical Expertise
- Urothelial carcinoma, Prostate cancer, Kidney cancer, Testicular cancer, Clinical research, Drug development, Medical oncology
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2017- Vanderbilt University Medical CenterResidency, Internal Medicine, 2012 - 2014
Vanderbilt University School of MedicineClass of 2012
Work Experience
Tennessee OncologyDirector Of Genitourinary Clinical Research · January 2025 - Current- Tennessee OncologyDirector Of Genitourinary Medical Oncology · January 2025 - Current
Vanderbilt University Medical Center (Nashville, TN)Assistant Professor · July 2018 - December 2024
Certifications & Licensure
TN State Medical License 2014 - 2026
AL State Medical License 2020 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.Rana R McKay, Sumanta Pal, Wanling Xie, David Aggen, Laurence Albiges
CA. 2025-12-13 - The safety profile of belzutifan in renal tumors: real-world data from a tertiary academic center.Aaron Jacob Winer, Paulo Siqueira do Amaral, Elizabeth G Ryan, Morgan A Lambrecht, Chiu-Lan Chen
The Oncologist. 2025-09-01 - 13 citationsSystemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.Rohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, R Bryan Rumble, Mary-Ellen Taplin
Journal of Clinical Oncology. 2025-07-10
Authored Content
- KEYMAKER-U03 Trial: Combinatorial Therapies for IO-Refractory Kidney Cancer - Kathryn BeckermannFebruary 2025
Press Mentions
- Aravive Announces First Patient Dosed in Phase 1b/2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell CarcinomaMarch 8th, 2021
Optimizing Benefit and Limiting Immune-Related Adverse Effects Following Checkpoint Inhibitor BlockadeJuly 3rd, 2018
May 16th, 2018 Young Lung Cancer Investigators Awarded $200K to Improve Lung Cancer OutcomesMay 16th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
